Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Roche, Boehringer tap biosensor firms for patient studies

A new dawn of the genomic age: five areas set to be transformed in 2023

ABPI code updated with first social media guidance

NICE recommends first CAR-T cell therapy on NHS in England

EU clears Enhertu for HER2-low breast cancer

spinal injury

Neuralink_implant

Digital/ News/ News

Elon Musk’s Neuralink brain interface chip set for human trials

Phil Taylor blindness, digital, digital health, Neuralink, neurology, spinal injury 0 Comment

Clinical trials of a wireless brain chip developed by Elon Musk’s Neuralink company will be tested in human

X

Elon Musk’s Neuralink brain interface chip set for human trials

https://pharmaphorum.com/news/elon-musks-neuralink-brain-interface-chip-set-for-human-trials/

AbbVieHQ

News/ News/ R&D

FDA fast-tracks AbbVie’s spinal injury drug

Richard Staines AbbVie, fda, R&D, spinal injury 0 Comment

The FDA has fast tracked development of AbbVie’s potential spinal injury drug, elezanumab, a process that will be

X

FDA fast-tracks AbbVie’s spinal injury drug

https://pharmaphorum.com/news/fda-fast-tracks-abbvies-spinal-injury-drug/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

ALS drug tofersen will face FDA advisors, says Biogen
Amazon unveils $5 subscription service for generics
NICE recommends first CAR-T cell therapy on NHS in England
Lilly injects $450m into plant making Mounjaro
ABPI code updated with first social media guidance

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2023

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com